Peroxisome Proliferator-Activated Receptor γ Activity Is Deficient in Alveolar Macrophages in Pulmonary Sarcoidosis

American Journal of Respiratory Cell and Molecular Biology

Volumn 30, Issue 1, 2004, Pages 1-5

  Culver, Daniel A ^a   Barna, Barbara P ^a   Raychaudhuri, Baisakhi ^a   Bonfield, Tracey L ^a   Abraham, Susamma ^a   Malur, Anagha ^a   Farver, Carol F ^a   Kavuru, Mani S ^a   Thomassen, Mary Jane ^a  

^a LERNER RESEARCH INSTITUTE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; NUCLEAR PROTEIN; PEROXISOME PROLIFERATOR ACTIVATED RECEPTOR GAMMA; TRANSCRIPTION FACTOR;

ADULT; ARTICLE; BRONCHOSCOPY; CLINICAL ARTICLE; CONTROLLED STUDY; DATA ANALYSIS; DISEASE COURSE; FEMALE; GEL MOBILITY SHIFT ASSAY; GENE EXPRESSION; HUMAN; HUMAN CELL; HYPOTHESIS; IMMUNOHISTOCHEMISTRY; INFLAMMATION; INHIBITION KINETICS; LUNG ALVEOLUS MACROPHAGE; LUNG LAVAGE; MALE; PATIENT; PROTEIN DEFICIENCY; REAL TIME POLYMERASE CHAIN REACTION; SARCOIDOSIS; UPREGULATION;

BASE SEQUENCE; DNA PRIMERS; ELECTROPHORETIC MOBILITY SHIFT ASSAY; GENE EXPRESSION; HUMANS; IMMUNOHISTOCHEMISTRY; MACROPHAGES, ALVEOLAR; NF-KAPPA B; RECEPTORS, CYTOPLASMIC AND NUCLEAR; SARCOIDOSIS, PULMONARY; TRANSCRIPTION FACTORS;

EID: 0346373643     PISSN: 10441549     EISSN: None     Source Type: Journal    
DOI: 10.1165/rcmb.2003-0304RC     Document Type: Article

References (33)

1. Baughman, R. P., A. S. Teirstein, M. A. Judson, M. D. Rossman, H. Yeager, Jr., E. A. Bresnitz, L. DePalo, G. Hunninghake, M. C. Iannuzzi, C. J. Johns, G. McLennan, D. R. Moller, L. S. Newman, D. L. Rabin, C. Rose, B. Rybicki, S. E. Weinberger, M. L. Terrin, G. L. Knatterud, and R. Cherniak. 2001. Clinical characteristics of patients in a case control study of sarcoidosis. Am. J. Respir. Crit. Care Med. 164:1885-1889.
2. Shigehara, K., N. Shijubo, M. Ohmichi, R. Takahashi, S. Kon, H. Okamura, M. Kurimoto, Y. Hiraga, T. Tatsuno, S. Abe, and N. Sato. 2001. IL-12 and IL-18 are increased and stimulate IFN-gamma production in sarcoid lungs. J. Immunol. 166:642-649.
3. Hunninghake, G. W., G. N. Bedell, D. C. Zavala, M. Monick, and M. Brady. 1983. Role of interleukin-2 release by lung T-cells in active pulmonary sarcoidosis. Am. Rev. Respir. Dis. 128:634-638.
4. Li, M., G. Pascual, and C. K. Glass. 2000. Peroxisome proliferator-activated receptor gamma-dependent repression of the inducible nitric oxide synthase gene. Mol. Cell. Biol. 20:4699-4707.
5. Ricote, M., A. C. Li, T. M. Willson, C. J. Kelly, and C. K. Glass. 1998. The peroxisome proliferator-activated receptor-gamma is a negative regulator of macrophage activation. Nature 391:79-82.
6. Ricote, M., J. T. Huang, J. S. Welch, and C. K. Glass. 1999. The peroxisome proliferator-activated receptor(PPARgamma) as a regulator of monocyte/macrophage function. J. Leukoc. Biol. 66:733-739.
7. Rosen, E. D., and B. M. Spiegelman. 2000. Peroxisome proliferator- activated receptor gamma ligands and atherosclerosis: ending the heartache. J. Clin. Invest. 106:629-631.
8. Lewis, J. D., G. R. Lichtenstein, R. B. Stein, J. J. Deren, T. A. Judge, F. Fogt, E. E. Furth, E. J. Demissie, L. B. Hurd, C. G. Su, S. A. Keilbaugh, M. A. Lazar, and G. D. Wu. 2001. An open-label trial of the PPAR-gamma ligand rosiglitazone for active ulcerative colitis. Am. J. Gastroenterol. 96: 3323-3328.
9. Kielian, T., and P. D. Drew. 2003. Effects of peroxisome proliferator-activated receptor-gamma agonists on central nervous system inflammation. J. Neurosci. Res. 71:315-325.
10. Patel, H. J., M. G. Belvisi, D. Bishop-Bailey, M. H. Yacoub, and J. A. Mitchell. 2003. Activation of peroxisome proliferator-activated receptors in human airway smooth muscle cells has a superior anti-inflammatory profile to corticosteroids: relevance for chronic obstructive pulmonary disease therapy. J. Immunol 170:2663-2669.
11. Bonfield, T. L., C. F. Farver, B. P. Barna, A. Malur, S. Abraham, B. Raychaudhuri, M. S. Kavuru, and M. J. Thomassen. 2003. Peroxisome proliferator-activated receptor-γ is deficient in alveolar macrophages from patients with alveolar proteinosis. Am. J. Respir. Cell Mol. Biol. 29:671-682.
12. Wang, A. C., X. Dai, B. Luu, and D. J. Conrad. 2001. Peroxisome proliferator-activated receptor-gamma regulates airway epithelial cell activation. Am. J. Respir. Cell Mol. Biol. 24:688-693.
13. Shingo, A., H. Golpon, C. D. Cool, D. Chan, R. W. Vandivier, S. J. Gardai, M. Wick, R. A. Nemenoff, M. W. Geraci, and N. F. Voelkel. 2003. Peroxisome proliferator-activated receptor gamma expression is decreased in pulmonary hypertension and affects endothelial cell growth. Circ. Res. 92:1162-1169.
14. 1994. Consensus conference: activity of sarcoidosis. Third WASOG meeting. Los Angeles, USA, September 8-11, 1993. Eur. Respir. J. 7:624-627.
15. Thomassen, M. J., L. T. Buhrow, M. J. Connors, F. T. Kaneko, S. C. Erzurum, and M. S. Kavuru. 1997. Nitric oxide inhibits inflammatory cytokine production by human alveolar macrophages. Am. J. Respir. Cell Mol. Biol. 17:279-283.
16. Livak, K. J., and T. D. Schmittgen. 2001. Analysis of relative gene expression data using real-time quantitative PCR and the 2(-Delta Delta C(T)) Method. Methods 25:402-408.
17. Users Bulletin #2 ABI Prism 7700 sequence detection system (updated 10/2001). Applied Biosystems, Foster City, CA.
18. Drent, M., R. van den Berg, G. R. Haenen, H. van den Berg, E. F. Wouters, and A. Bast. 2001. NF-kappaB activation in sarcoidosis. Sarcoidosis Vasc. Diffuse Lung Dis. 18:50-56.
19. Ruan, H., H. J. Pownall, and H. F. Lodish. 2003. Troglitazone antagonizes tumor necrosis factor-α-induced reprogramming of adipocyte gene expression by inhibiting the transcriptional regulatory functions of NF-κB. J. Biol. Chem. 278:28181-28192.
20. Minshall, E. M., A. Tsicopoulos, Z. Yasruel, B. Wallaert, H. Akoum, H. Vorng, A. B. Tonnel, and Q. Hamid. 1997. Cytokine mRNA gene expression in active and nonactive pulmonary sarcoidosis. Eur. Respir. J. 10:2034-2039.
21. Jiang, C., A. T. Ting, and B. Seed. 1998. PPAR-gamma agonists inhibit production of monocyte inflammatory cytokines. Nature 391:82-86.
22. Alleva, D. G., E. B. Johnson, F. M. Lio, S. A. Boehme, P. J. Conlon, and P. D. Crowe. 2002. Regulation of murine macrophage proinflammatory and anti-inflammatory cytokines by ligands for peroxisome proliferator-activated receptor-gamma: counter-regulatory activity by IFN-gamma. J. Leukoc. Biol. 71:677-685.
23. Welch, J. S., M. Ricote, T. E. Akiyama, F. J. Gonzalez, and C. K. Glass. 2003. PPARgamma and PPARdelta negatively regulate specific subsets of lipopolysaccharide and IFN-gamma target genes in macrophages. Proc. Natl. Acad. Sci. USA 100:6712-6717.
24. Saubermann, L. J., A. Nakajima, K. Wada, S. Zhao, Y. Terauchi, T. Kadowaki, H. Aburatani, N. Matsuhashi, R. Nagai, and R. S. Blumberg. 2002. Peroxisome proliferator-activated receptor gamma agonist ligands stimulate a Th2 cytokine response and prevent acute colitis. Inflamm. Bowel Dis. 8:330-339.
25. Oyama, Y., M. Kurabayashi, N. Akuzawa, and R. Nagai. 2000. Troglitazone, a PPARgamma ligand, inhibits osteopontin gene expression in human monocytes/macrophage THP-1 cells. J. Atheroscler. Thromb. 7:77-82.
26. Bergeron, A., M. Bonay, M. Kambouchner, D. Lecossier, M. Riquet, P. Soler, A. Hance, and A. Tazi. 1997. Cytokine patterns in tuberculous and sarcoid granulomas: correlations with histopathologic features of the granulomatous response. J. Immunol. 159:3034-3043.
27. Petrek, M., V. Kolek, J. Szotkowska, and R. M. du Bois. 2002. CC and C chemokine expression in pulmonary sarcoidosis. Eur. Respir. J. 20:1206-1212.
28. O'Regan, A. W., G. L. Chupp, J. A. Lowry, M. Goetschkes, N. Mulligan, and J. S. Berman. 1999. Osteopontin is associated with T cells in sarcoid granulomas and has T cell adhesive and cytokine-like properties in vitro. J. Immunol. 162:1024-1031.
29. Fehrenbach, H., G. Zissel, T. Goldmann, T. Tschernig, E. Vollmer, R. Pabst, and J. Muller-Quernheim. 2003. Alveolar macrophages are the main source for tumour necrosis factor-alpha in patients with sarcoidosis. Eur. Respir. J. 21:421-428.
30. Moller, D. R. 1999. Cells and cytokines involved in the pathogenesis of sarcoidosis. Sarcoidosis Vasc. Diffuse Lung Dis. 16:24-31.
31. Waite, K. J., Z. E. Floyd, P. Arbour-Reily, and J. M. Stephens. 2001. Interferon-gamma-induced regulation of peroxisome proliferator-activated receptor gamma and STATs in adipocytes. J. Biol. Chem. 276:7062-7068.
32. Floyd, Z. E., and J. M. Stephens. 2002. Interferon-gamma-mediated activation and ubiquitin-proteasome-dependent degradation of PPARgamma in adipocytes. J. Biol. Chem. 277:4062-4068.
33. Shiojiri, T., K. Wada, A. Nakajima, K. Katayama, A. Shibuya, C. Kudo, T. Kadowaki, T. Mayumi, Y. Yura, and Y. Kamisaki. 2002. PPAR gamma ligands inhibit nitrotyrosine formation and inflammatory mediator expressions in adjuvant-induced rheumatoid arthritis mice. Eur. J. Pharmacol. 448:231-238.